Showing 561 - 580 results of 1,038 for search '(( significant decrease decrease ) OR ( significant binding decrease ))~', query time: 0.30s Refine Results
  1. 561

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  2. 562

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  3. 563

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  4. 564

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  5. 565

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  6. 566

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  7. 567

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  8. 568

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  9. 569

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  10. 570

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  11. 571

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  12. 572

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  13. 573

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  14. 574

    S1_raw_images. by Lijun Mao (561880)

    Published 2025
    “…Mechanism investigations revealed that miR-122 directly suppressed the expression of RBM47, which was a novel RNA binding protein. RBM47 decreased the level of α<sub>v</sub> integrin (ITGAV) by promoting the degradation of mRNA via interacting with the AU-rich elements in its 3’UTR. …”
  15. 575

    Raw data for graphs. by Lijun Mao (561880)

    Published 2025
    “…Mechanism investigations revealed that miR-122 directly suppressed the expression of RBM47, which was a novel RNA binding protein. RBM47 decreased the level of α<sub>v</sub> integrin (ITGAV) by promoting the degradation of mRNA via interacting with the AU-rich elements in its 3’UTR. …”
  16. 576

    The predicted AREs in the 3’UTR of ITGAV mRNA. by Lijun Mao (561880)

    Published 2025
    “…Mechanism investigations revealed that miR-122 directly suppressed the expression of RBM47, which was a novel RNA binding protein. RBM47 decreased the level of α<sub>v</sub> integrin (ITGAV) by promoting the degradation of mRNA via interacting with the AU-rich elements in its 3’UTR. …”
  17. 577
  18. 578
  19. 579
  20. 580

    Original values used to build graphs. by Min Qin (123347)

    Published 2025
    “…Joint analysis of RNA-seq and m<sup>6</sup>A-seq data was utilized for enriching differentially expressed genes (DEGs) with significantly altered m<sup>6</sup>A modifications. Intriguingly, following <i>T. gondii</i> infection, the m<sup>6</sup>A levels of DEGs associated with toxoplasmosis, TNF signaling pathway, and NF-κB signaling pathway were significantly different. …”